Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing and tissue repair after heart attack, in a study published in Cell Metabolism.
A treatment of inhaled inorganic nitrite did not improve exercise capacity among patients with a common form of heart failure, according to a clinical trial published in JAMA.
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
Adults who develop high blood pressure before the age of 40 are at a significantly higher risk for cardiovascular events later in life, according to a Northwestern Medicine study.
Northwestern Medicine scientists demonstrated the efficacy of novel treatments for heart failure and provided new insights into mechanisms of the disease, in three recent studies.
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study.
Northwestern Medicine scientists have identified a novel mechanism for how mutations in desmoplakin — a protein that helps cells stick together — can lead to cardiac arrhythmias and other diseases.
Northwestern Medicine scientists have shown for the first time how an RNA-binding protein in the liver plays an important role in regulating insulin sensitivity throughout the body.
A protein called tristetraprolin is activated during iron deficiency, lowering iron usage and preventing mitochondrial dysfunction, according to a recent Northwestern Medicine study.
The American Heart Association recently selected Northwestern Medicine as one of six centers to be part of a new, grant-funded national network dedicated to researching and understanding the causes of atrial fibrillation, the most common type of irregular heartbeat.